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LETTERS
Angiostrongyliasis 
in the Americas 
To the Editor: We read with spe-
cial interest the article by Hochberg et 
al. about angiostrongyliasis in Hawaii 
(1). Angiostrongylus cantonensis men-
ingitis in the Americas was reported 
by Aguiar et al. in Cuba in 1981 (2), 
and we have studied this zoonosis dur-
ing  the  ensuing  25  years.  We  agree 
with the authors about the difficulty in 
obtaining a specific immunoassay for 
detection of antibodies to A. cantonen-
sis antigens. In Cuba, as in Hawaii, no 
other cause of eosinophilic meningitis 
was identified. 
To improve accuracy of the diag-
nosis we investigated immunoglobu-
lin (Ig) E intrathecal synthesis during 
the  first  diagnostic  lumbar  puncture. 
We also confirmed this synthesis as ei-
ther a 2-class response (IgG + IgA) or 
a 3-class response (IgG + IgA + IgM) 
that appeared 8 days later in cerebro-
spinal fluid (3). 
Since  1991,  our  records  show 
that the major incidence of the dis-
ease is during the second quarter of 
the  year.  We  detected  32%  of  the 
cases during the rainy season when 
rats  come  into  houses  in  rural  and 
semirural areas and snails and slugs 
appear  more  often  in  gardens  and 
yards where children play. Ethnicity 
data show that 52% of those affected 
were Caucasian and 32% were Afri-
can. The median interval from onset 
of symptoms to lumbar puncture was 
1–3 days. Although no children died, 
6 (23%) of 26 adult patients died. The 
clinical  signs  and  symptoms  of  the 
Cuban  patients  are  similar  to  those 
in Hawaii (4,5). We congratulate the 
authors for systematically determin-
ing incidence rates of A. cantonensis 
meningoencephalitis,  a  severe  but 
preventable infection. 
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Increase in Group G 
Streptococcal  
Infections in a  
Community Hospital,   
New York, USA
To the Editor: Identified in 1935 
by  Lancefield  and  Hare,  group  G 
streptococci (GGS) are part of the nor-
mal flora of the pharynx, gastrointesti-
nal tract, genital tract, and skin (1–3). 
However, previous case reports have 
indicated that GGS also could cause 
complicated infections, including cel-
lulitis,  osteomyelitis,  septic  arthritis, 
meningitis,  endocarditis,  and  bacter-
emia (3–6). Since the mid-1980s, sev-
eral studies worldwide have reported 
an increasing incidence of GGS bacte-
remia (1,5–8), but no recent study has 
been conducted in the United States 
to determine the incidence of overall 
GGS infection.
We  noticed  that  an  increasing 
number  of  patients  with  GGS  have 
been  admitted  to  Long  Island  Col-
lege Hospital in Brooklyn, New York, 
USA, during the past few years. To 
better understand the trend of GGS 
infection in our institution, we retro-
spectively reviewed charts of patients 
admitted from January 2003 through 
December 2007 who had microbio-
logically proven GGS infection. In-
clusion  criteria  were  clinically  and 
microbiologically  documented  GGS 
infection  in  patients  who  received 
appropriate  antimicrobial  drugs  and 
were  >18  years  of  age.  Lancefield 
GGS were identified in the laboratory 
by latex agglutination test; resistance 
profiles were not done for GGS.
A total of 73 persons with GGS 
were admitted to the hospital during 
the  5-year  study  period;  the  num-
ber  of  patients  admitted  increased 
yearly (Figure). Mean age of patients 
was 53 years; most (77%) were <65 
years of age; 52% were women, and 
most  (61%)  patients  were  African 
American. Thirty (41%) patients had 
polymicrobial infections; other identi-
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fied  organisms  included  methicillin-
susceptible Staphylococcus aureus (8 
[11%]), methicillin-resistant S. aureus 
(MRSA) (9 [12%]), and gram-negative 
or anaerobic organisms (13 [18%]).
The spectrum of GGS infections 
ranged from mild skin and soft tis-
sue infection (34 [46%]) to invasive 
diseases, including urogenital infec-
tion  (7  [10%]);  lower  respiratory 
tract infection (7 [10%]); pharyngitis 
(6  [8%]);  endocarditis  and  catheter 
infection  (5  [7%]);  and  others  (14 
[19%]),  such  as  peritonitis,  pelvic 
abscess,  rectal  abscess,  and  septic 
arthritis. Four of the 6 persons with 
pharyngitis were assumed to be colo-
nized with the organism. Eight (24%) 
of 34 skin and soft tissue infections 
were  associated  with  bacteremia,  5 
(15%)  with  osteomyelitis,  and  20 
(59%) with polymicrobial infections. 
Six  persons  with  lower  respiratory 
tract infections and 1 each with endo-
carditis, genital tract infection, pelvic 
abscess, and dental abscess also had 
polymicrobial infections.
Eighteen  persons  had  bactere-
mia, the trend of which also increased 
yearly. Of these, 8 had skin and soft 
tissue infections, 4 had endocarditis, 
2 had urinary tract infections, 1 had 
possible spontaneous bacteria perito-
nitis, and 1 had hemodialysis catheter 
infection; 2 were of unknown source. 
Of the patients with endocarditis, 2 
had vegetations on the native valves, 
1 had a pacemaker infection, and 1 
had prosthetic valve vegetation. One 
case of native valve endocarditis oc-
curred in a tricuspid valve in an injec-
tion drug user. Another case occurred 
in a patient in which an epidural ab-
scess  was  associated  with  an  aortic 
valve vegetation.
Most of the patients had underly-
ing medical conditions; 34% had dia-
betes mellitus. In contrast to previous 
reports, which stated that malignancy 
was  the  most  common  underlying 
disease (2,3), only 7 (10%) of the pa-
tients in our study group had underly-
ing malignancy, of whom 4 had active 
malignancy and the rest had had pre-
vious malignancy. Nine patients with 
a history of injection drug use and 5 
with  HIV  infection  were  identified; 
the patient with bacteremia secondary 
to hemodialysis catheter infection had 
a history of both HIV and intravenous 
drug use.
Three  (4%)  patients  died;  their 
deaths were unlikely to be attribut-
able to GGS because all were elderly 
(78–92  years)  and  had  underlying 
coexisting  conditions  and  co-infec-
tions. All 4 persons with endocardi-
tis and the patient with the catheter 
infection survived. Five patients who 
were  co-infected  with  MRSA  were 
treated with vancomycin or daptomy-
cin; the remainder were treated with 
β-lactam antimicrobial drugs and had 
the sources of infection (catheter or 
pacemaker)  removed.  When  infec-
tions  caused  by  gram-negative  or 
anaerobe organisms were identified, 
they were also treated with appropri-
ate antimicrobial drugs. The overall 
average length of stay for all patients 
with GGS was 9.4 days, with longer 
stays for those with underlying diabe-
tes mellitus (14.6 days) than for those 
without diabetes (6.7 days).
GGS was an important etiologic 
agent for a wide spectrum of infec-
tions. Its impressive increase in our 
institution  during  the  past  5  years 
raises  concerns  because  other  types 
of  β-hemolytic  streptococcal  infec-
tion have increased recently. Group A 
and B (9,10) increased substantially 
during the 1980s. A multicenter anal-
ysis may confirm GGS as an emerg-
ing human pathogen and may help us 
better understand the reason for this 
increase.
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Figure. Annual number of patients with group G streptococcal infections admitted to Long 
Island College Hospital, Brooklyn, New York, USA, 2003–2007.
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New Saffold  
Cardiovirus in  
Children, China 
To the Editor: A new member of 
the genus Cardiovirus, termed Saffold 
virus  (SAFV), was discovered recent-
ly in stool specimens and nasopharyn-
geal  aspirate  samples  from  patients 
with fever of unknown origin, respi-
ratory  symptoms,  or  gastroenteritis; 
these  have  been  considered  the  first 
documented  reports  of  cardiovirus 
infection in humans (1–4). However, 
the epidemiologic characteristics and 
pathogenic  role  of  the  virus  are  not 
fully understood.
From  July  2006  through  June 
2008, stool specimens were collected 
from  631  hospitalized  children  with 
diarrhea and 161 asymptomatic con-
trols in Lanzhou, People’s Republic of 
China. All children were <5 years of 
age (median age 8 months, range 0–60 
months). Diarrhea was defined as >3 
loose stools in the previous 24–72 h. 
Controls were asymptomatic children 
who  had  been  brought  to  the  First 
Hospital of Lanzhou University Pedi-
atric Primary Care Center for a routine 
checkup and had not had fever, diar-
rhea, vomiting, or a respiratory illness 
in  the  previous  3  weeks.  The  stool 
specimens were then transported to the 
Chinese  Center  for  Disease  Control 
and  Prevention,  Beijing,  to  undergo 
screening for common enteric viruses. 
The specimens were tested for rotavi-
rus by using a commercially available 
ELISA kit (IDEIA Rotavirus; DAKO, 
Glostrup, Denmark), and PCR and re-
verse transcription PCR (5) were used 
to screen for other common enteric vi-
ruses, including norovirus, sapovirus, 
astrovirus, and adenovirus.
Viral  RNA  and  DNA  were  ex-
tracted from 140 µL of 10% fecal sus-
pension in phosphate-buffered saline 
by using QIAamp Viral RNA Mini Kit 
(QIAGEN,  Hilden,  Germany);  viral 
RNA and DNA was supposed to be 
extracted  simultaneously,  according 
to the manufacturer’s instructions. Ex-
tracts of nucleic acid were tested for 
SAFV by a nested PCR that targeted 
the 5′ untranslated region (UTR) gene 
as  described  by  Drexler  et  al.  (4). 
The viral protein 1 (VP1) gene from 
positive  samples  was  amplified  as 
described by Chiu et al. (3). Positive 
bands were cloned and sequenced in 
both directions.
By  confirming  sequences  of  the 
5′  UTR  gene,  3  (0.5%)  specimens 
from  the  631  children  with  diarrhea 
(LZ50419,  LZ52903,  LZ53879)  and 
1 (0.6%) from the 161 asymptomatic 
children (LZ53010) were found to be 
positive for SAFV. Of the 4 positive 
specimens, 2 were collected in Octo-
ber, 1 in September, and 1 in June. The 
median age of the 4 patients with posi-
tive specimens was 6 months (range 
2–25 months). Viral co-infection was 
detected in the 3 children with diarrhea 
who had SAFV-positive specimens; 2 
were co-infected with rotavirus and 1 
with  norovirus.  No  co-infection  was 
detected  in  the  asymptomatic  child 
with SAFV-positive results. 
The 0.5% detection rate of SAFV 
in children with diarrhea in our study 
is  lower  than  the  1.2%  reported  by 
Chiu et al. (3). One possible reason 
could be that the patients in our study 
were younger (median age 8 months), 
but in other studies, the median age 
was  20  months  for  all  patients  with 
confirmed cases. Nonetheless, the sea-
sonal distribution of the positive cases 
in our study is in accordance with the 
result of Drexler et al. (4), namely, in 
late summer and early fall.
The 5′ UTR sequences of the 4 
positive  samples  were  deposited  in 
GenBank  (accession  nos.  FJ586238, 
FJ586239, FJ610244, and FJ623968). 
After several trials, only the VP1 se-
quence of sample LZ50419 was am-
plified (accession no. FJ586240). The 
obtained  sequences  were  analyzed 
by  using  the  DNASTAR  software 
package  (DNASTAR,  Madison,  WI, 
USA). A BLAST search (http://blast.
ncbi.nlm.nih.gov/Blast.cgi)  demon-
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